专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明授权

US08027724B2 Hypertension diagnosis and therapy using pressure sensor 有权
标题翻译：高血压诊断和治疗使用压力传感器
公开(公告)号：US08027724B2
公开(公告)日：2011-09-27
申请号：US11833435
申请日：2007-08-03
申请人： Xuan Wei , Cheng Zhang , Shantha Arcot-Krishnamurthy , Dan Li
发明人： Xuan Wei , Cheng Zhang , Shantha Arcot-Krishnamurthy , Dan Li
IPC分类号： A61N1/08
CPC分类号： A61N1/36564 , A61B5/0031 , A61B5/0215 , A61N1/36114 , A61N1/36117
摘要： An example relates to a method for sensing a pulmonary artery pressure (PAP) and providing a sensed PAP signal, detecting an abnormal blood pressure (BP) condition using information from the sensed PAP signal, delivering a pacing energy to a heart, and automatically altering at least one pacing characteristic in response to the detected abnormal BP condition. The detecting an abnormal BP condition can include detecting various forms of hypertension or hypotension. The automatically altering the at least one pacing characteristic can include automatically altering at least one of a pacing rate, a pacing waveform, an atriventricular (AV) delay, an interventricular (VV) delay, a pacing mode, or a pacing site. The method can also include delivering vagal nerve stimulation and automatically altering the vagal nerve stimulation in response to the detected abnormal BP condition. The detecting the abnormal BP condition can also include using a sensed auxiliary physiological parameter.
摘要翻译：一个例子涉及一种用于感测肺动脉压（PAP）并提供感测到的PAP信号的方法，使用来自感测到的PAP信号的信息检测异常血压（BP）状况，将起搏能量递送到心脏，并且自动改变响应于检测到的异常BP状况的至少一个起搏特征。检测异常BP病症可包括检测各种形式的高血压或低血压。自动改变至少一个起搏特征可以包括自动改变起搏速率，起搏波形，房室（AV）延迟，心室间（VV）延迟，起搏模式或起搏部位中的至少一个。该方法还可以包括递送迷走神经刺激并响应于检测到的异常BP状况自动改变迷走神经刺激。检测异常BP状况还可以包括使用感测的辅助生理参数。

2. 发明申请

US20090036940A1 HYPERTENSION DIAGNOSIS AND THERAPY USING PRESSURE SENSOR 有权
标题翻译：使用压力传感器进行高血压诊断和治疗
公开(公告)号：US20090036940A1
公开(公告)日：2009-02-05
申请号：US11833435
申请日：2007-08-03
申请人： Xuan Wei , Cheng Zhang , Shantha Arcot-Krishnamurthy , Dan Li
发明人： Xuan Wei , Cheng Zhang , Shantha Arcot-Krishnamurthy , Dan Li
IPC分类号： A61N1/365
CPC分类号： A61N1/36564 , A61B5/0031 , A61B5/0215 , A61N1/36114 , A61N1/36117
摘要： An example relates to a method for sensing a pulmonary artery pressure (PAP) and providing a sensed PAP signal, detecting an abnormal blood pressure (BP) condition using information from the sensed PAP signal, delivering a pacing energy to a heart, and automatically altering at least one pacing characteristic in response to the detected abnormal BP condition. The detecting an abnormal BP condition can include detecting various forms of hypertension or hypotension. The automatically altering the at least one pacing characteristic can include automatically altering at least one of a pacing rate, a pacing waveform, an atriventricular (AV) delay, an interventricular (VV) delay, a pacing mode, or a pacing site. The method can also include delivering vagal nerve stimulation and automatically altering the vagal nerve stimulation in response to the detected abnormal BP condition. The detecting the abnormal BP condition can also include using a sensed auxiliary physiological parameter.
摘要翻译：一个例子涉及一种用于感测肺动脉压（PAP）并提供感测到的PAP信号的方法，使用来自感测到的PAP信号的信息检测异常血压（BP）状况，将起搏能量递送到心脏，并且自动改变响应于检测到的异常BP状况的至少一个起搏特征。检测异常BP病症可包括检测各种形式的高血压或低血压。自动改变至少一个起搏特征可以包括自动改变起搏速率，起搏波形，房室（AV）延迟，心室间（VV）延迟，起搏模式或起搏部位中的至少一个。该方法还可以包括递送迷走神经刺激并响应于检测到的异常BP状况自动改变迷走神经刺激。检测异常BP状况还可以包括使用感测的辅助生理参数。

3. 发明申请

US20070282381A1 METHOD AND APPARATUS FOR CLOSED-LOOP CONTROL OF ANTI-TACHYARRHYTHMIA PACING USING HEMODYNAMIC SENSOR 有权
标题翻译：使用血液动力学传感器进行抗沙眼衣原体闭环控制的方法和装置
公开(公告)号：US20070282381A1
公开(公告)日：2007-12-06
申请号：US11422101
申请日：2006-06-05
申请人： Dan Li , Cheng Zhang
发明人： Dan Li , Cheng Zhang
IPC分类号： A61N1/362
CPC分类号： A61N1/3622 , A61N1/3712
摘要： A cardiac rhythm management (CRM) system includes an implantable medical device that delivers anti-tachyarrhythmia therapies including anti-tachyarrhythmia pacing (ATP) and a hemodynamic sensor that senses a hemodynamic signal. The implantable medical device includes a hemodynamic sensor-controlled closed-loop ATP system that uses the hemodynamic signal for ATP capture verification. When ATP pulses are delivered according to a selected ATP protocol to terminate a tachyarrhythmia episode, the implantable medical device performs the ATP capture verification by detecting an effective cardiac contraction from the hemodynamic signal. The ATP protocol is adjusted using an outcome of the ATP capture verification.
摘要翻译：心律管理（CRM）系统包括可植入的医疗装置，其传递抗心律失常疗法，包括抗心动过速起搏（ATP）和感测血液动力学信号的血液动力学传感器。可植入医疗装置包括血液动力学传感器控制的闭环ATP系统，其使用血流动力学信号进行ATP捕获验证。当根据选定的ATP方案递送ATP脉冲以终止快速性心律失常发作时，可植入医疗装置通过从血液动力学信号检测有效的心脏收缩来执行ATP捕获验证。使用ATP捕获验证的结果调整ATP方案。

4. 发明申请

US20100331905A1 METHOD AND APPARATUS FOR CLOSED-LOOP CONTROL OF ANTI-TACHYARRHYTHMIA PACING USING HEMODYNAMIC SENSOR 有权
标题翻译：使用血液动力学传感器进行抗沙眼衣原体闭环控制的方法和装置
公开(公告)号：US20100331905A1
公开(公告)日：2010-12-30
申请号：US12877583
申请日：2010-09-08
申请人： Dan Li , Cheng Zhang
发明人： Dan Li , Cheng Zhang
IPC分类号： A61N1/365
CPC分类号： A61N1/3622 , A61N1/3712
摘要： A cardiac rhythm management (CRM) system includes an implantable medical device that delivers anti-tachyarrhythmia therapies including anti-tachyarrhythmia pacing (ATP) and a hemodynamic sensor that senses a hemodynamic signal. The implantable medical device includes a hemodynamic sensor-controlled closed-loop ATP system that uses the hemodynamic signal for ATP capture verification. When ATP pulses are delivered according to a selected ATP protocol to terminate a tachyarrhythmia episode, the implantable medical device performs the ATP capture verification by detecting an effective cardiac contraction from the hemodynamic signal. The ATP protocol is adjusted using an outcome of the ATP capture verification.
摘要翻译：心律管理（CRM）系统包括可植入的医疗装置，其传递抗心律失常疗法，包括抗心动过速起搏（ATP）和感测血液动力学信号的血液动力学传感器。可植入医疗装置包括血液动力学传感器控制的闭环ATP系统，其使用血流动力学信号进行ATP捕获验证。当根据选定的ATP方案递送ATP脉冲以终止快速性心律失常发作时，可植入医疗装置通过从血液动力学信号检测有效的心脏收缩来执行ATP捕获验证。使用ATP捕获验证的结果调整ATP方案。

5. 发明授权

US08712525B2 Method and apparatus for closed-loop control of anti-tachyarrhythmia pacing using hemodynamic sensor 有权
标题翻译：使用血液动力学传感器闭合控制抗心律失常起搏的方法和装置
公开(公告)号：US08712525B2
公开(公告)日：2014-04-29
申请号：US12877583
申请日：2010-09-08
申请人： Dan Li , Cheng Zhang
发明人： Dan Li , Cheng Zhang
IPC分类号： A61N1/362
CPC分类号： A61N1/3622 , A61N1/3712
摘要： A cardiac rhythm management (CRM) system includes an implantable medical device that delivers anti-tachyarrhythmia therapies including anti-tachyarrhythmia pacing (ATP) and a hemodynamic sensor that senses a hemodynamic signal. The implantable medical device includes a hemodynamic sensor-controlled closed-loop ATP system that uses the hemodynamic signal for ATP capture verification. When ATP pulses are delivered according to a selected ATP protocol to terminate a tachyarrhythmia episode, the implantable medical device performs the ATP capture verification by detecting an effective cardiac contraction from the hemodynamic signal. The ATP protocol is adjusted using an outcome of the ATP capture verification.
摘要翻译：心律管理（CRM）系统包括可植入的医疗装置，其传递抗心律失常疗法，包括抗心动过速起搏（ATP）和感测血液动力学信号的血液动力学传感器。可植入医疗装置包括血液动力学传感器控制的闭环ATP系统，其使用血流动力学信号进行ATP捕获验证。当根据选定的ATP方案递送ATP脉冲以终止快速性心律失常发作时，可植入医疗装置通过从血液动力学信号检测有效的心脏收缩来执行ATP捕获验证。使用ATP捕获验证的结果调整ATP方案。

6. 发明授权

US07801608B2 Method and apparatus for closed-loop control of anti-tachyarrhythmia pacing using hemodynamic sensor 有权
标题翻译：使用血液动力学传感器闭合控制抗心律失常起搏的方法和装置
公开(公告)号：US07801608B2
公开(公告)日：2010-09-21
申请号：US11422101
申请日：2006-06-05
申请人： Dan Li , Cheng Zhang
发明人： Dan Li , Cheng Zhang
IPC分类号： A61N1/08
CPC分类号： A61N1/3622 , A61N1/3712
摘要： A cardiac rhythm management (CRM) system includes an implantable medical device that delivers anti-tachyarrhythmia therapies including anti-tachyarrhythmia pacing (ATP) and a hemodynamic sensor that senses a hemodynamic signal. The implantable medical device includes a hemodynamic sensor-controlled closed-loop ATP system that uses the hemodynamic signal for ATP capture verification. When ATP pulses are delivered according to a selected ATP protocol to terminate a tachyarrhythmia episode, the implantable medical device performs the ATP capture verification by detecting an effective cardiac contraction from the hemodynamic signal. The ATP protocol is adjusted using an outcome of the ATP capture verification.
摘要翻译：心律管理（CRM）系统包括可植入的医疗装置，其传递抗心律失常疗法，包括抗心动过速起搏（ATP）和感测血液动力学信号的血液动力学传感器。可植入医疗装置包括血液动力学传感器控制的闭环ATP系统，其使用血流动力学信号进行ATP捕获验证。当根据选定的ATP方案递送ATP脉冲以终止快速性心律失常发作时，可植入医疗装置通过从血液动力学信号检测有效的心脏收缩来执行ATP捕获验证。使用ATP捕获验证的结果调整ATP方案。

7. 外观设计

USD1020017S1 Belt light 有权
公开(公告)号：USD1020017S1
公开(公告)日：2024-03-26
申请号：US29834373
申请日：2022-04-11
申请人： Cheng Zhang
设计人： Cheng Zhang
摘要： FIG. 1 is a perspective view of a belt light showing my new design;
FIG. 2 is a front elevational view thereof;
FIG. 3 is a rear elevational view thereof;
FIG. 4 is a left side elevational view thereof;
FIG. 5 is a right side elevational view thereof;
FIG. 6 is a top plan view thereof; and,
FIG. 7 is a bottom plan view thereof.
The broken lines throughout the drawing figures depict portions of the belt light that form no part of the claimed design.

8. 发明申请

US20140258496A1 DATA CENTRE SYSTEM AND METHOD FOR A DATA CENTRE TO PROVIDE SERVICE 有权
标题翻译：数据中心系统和数据中心提供服务的方法
公开(公告)号：US20140258496A1
公开(公告)日：2014-09-11
申请号：US14346653
申请日：2012-07-17
申请人： Jiaoren Wu , Tao Liu , Ning Liu , Cheng Zhang , Jiang Fu
发明人： Jiaoren Wu , Tao Liu , Ning Liu , Cheng Zhang , Jiang Fu
IPC分类号： H04L12/803
CPC分类号： H04L47/125 , H04L29/06 , H04L61/1511 , H04L61/251 , H04L61/2528 , H04L61/6086 , H04L67/1002 , H04L67/1023
摘要： A data center system and a method for a data center to provide service are provided. The data center system comprises at least one first load balancing device, a plurality of second load balancing devices, and a plurality of servers. The first load balancing device is configured to transmit the first type network request to one of the plurality of second load balancing devices with a first scheduling strategy. The second load balancing device is configured to convert the first type network request to a second type network request, and to transmit the second type network request after the source address and destination address translation to one of the plurality of servers with a second scheduling strategy. The server is configured to generate a second type network response according to the second type network request and to return the second type network response to a corresponding second load balancing device.
摘要翻译：提供数据中心系统和数据中心提供服务的方法。数据中心系统包括至少一个第一负载平衡装置，多个第二负载平衡装置和多个服务器。第一负载平衡装置被配置为以第一调度策略将第一类型网络请求发送到多个第二负载平衡装置之一。第二负载平衡装置被配置为将第一类型网络请求转换为第二类型网络请求，并且在源地址和目的地地址转换之后，以第二调度策略向多个服务器之一发送第二类型网络请求。服务器被配置为根据第二类型网络请求生成第二类型网络响应，并且将第二类型网络响应返回到对应的第二负载平衡设备。

9. 发明申请

US20130231369A1 1-[(4-hydroxypiperidin-4-yl)methyl]pyridin-2(1H)-one derivatives, preparation methods and uses thereof 有权
标题翻译： 1 - [（4-羟基哌啶-4-基）甲基]吡啶-2（1H） - 酮衍生物，其制备方法和用途
公开(公告)号：US20130231369A1
公开(公告)日：2013-09-05
申请号：US13697857
申请日：2011-04-08
申请人： Yunfeng Li , Rifang Yang , Youzhi Zhang , Yongzhen Li , Zengliang Jin , Peng Li , Li Yuan , Liuhong Yun , Nan Zhao , Cheng Zhang , Xiaodan Xu , Rusheng Zhao , Hongxia Chen , Rui Xue , Juanjuan Qin , Zhenzhen Wang , Jiazhi Yao
发明人： Yunfeng Li , Rifang Yang , Youzhi Zhang , Yongzhen Li , Zengliang Jin , Peng Li , Li Yuan , Liuhong Yun , Nan Zhao , Cheng Zhang , Xiaodan Xu , Rusheng Zhao , Hongxia Chen , Rui Xue , Juanjuan Qin , Zhenzhen Wang , Jiazhi Yao
IPC分类号： C07D401/06
CPC分类号： C07D401/06
摘要： Provided are N-[(4-hydroxypiperidin-4-yl)methyl]pyridin-2(1H)-one derivatives represented by formula I, stereoisomers, pharmaceutically acceptable salts or solvates thereof. The above compounds have the dual activities of 5-hydroxytryptamine 1A receptor ligand and selective serotonin reuptake inhibitor. The preparation methods of the above compounds, the uses of these compounds for the prevention or treatment of nervous system diseases related to 5-hydroxytryptamine system dysfunction and the pharmaceutical compositions containing these compounds are also provided.
摘要翻译：提供由式I表示的N - [（4-羟基哌啶-4-基）甲基]吡啶-2（1H） - 酮衍生物，其立体异构体，药学上可接受的盐或溶剂合物。上述化合物具有5-羟色胺1A受体配体和选择性5-羟色胺再摄取抑制剂的双重活性。还提供了上述化合物的制备方法，这些化合物用于预防或治疗与5-羟色胺系统功能障碍有关的神经系统疾病的用途和含有这些化合物的药物组合物。

10. 发明授权

US08445563B2 Utilization of kraft lignin in phenol/formaldehyde bonding resins for OSB 有权
公开(公告)号：US08445563B2
公开(公告)日：2013-05-21
申请号：US12947703
申请日：2010-11-16
申请人： Jack G. Winterowd , Cheng Zhang , Amar N. Neogi
发明人： Jack G. Winterowd , Cheng Zhang , Amar N. Neogi
IPC分类号： C08L97/02 , C08K5/13
CPC分类号： C08L97/02 , C08L61/06 , C08L97/005
摘要： A resin for OSB comprising an aqueous resole reaction product of phenol, formaldehyde, alkaline metal hydroxide or carbonate, urea and a degraded lignin polymer having 35-65% solids, a pH of 8-13 and a viscosity 50-1000 centipoises. The phenol and formaldehyde are present in a molar ratio of 1.5 to 3.4 moles formaldehyde to 1 mole phenol and are 40 to 85% of the total solids added to the mixture. In one embodiment they are 50 to 75% of the total solids added to the mixture. The alkaline metal hydroxide or carbonate are 5 to 20% of the total solids added to the mixture. Urea is 5 to 35% of the total solids added to the mixture. The degraded lignin is 5 to 20% of the total solids added to the mixture.A method for making the resin and a product using the resin.

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式